Site Reference ID/Investigator# 5243 — Washington D.C., District of Columbia

Site Reference ID/Investigator# 5243 is a clinical research site located in Washington D.C., District of Columbia, United States 20010.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site Reference ID/Investigator# 5243 has participated in 1 clinical trials.

Therapeutic areas: Advanced Renal Cell Carcinoma.

Sponsors: AbbVie (prior sponsor, Abbott).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Washington D.C.

Browse all research sites in District of Columbia · View every site in Washington D.C.

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site Reference ID/Investigator# 5243?

Site Reference ID/Investigator# 5243 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site Reference ID/Investigator# 5243 conducted?

Site Reference ID/Investigator# 5243 has 1 clinical trials on record. Their work covers Advanced Renal Cell Carcinoma.

Is Site Reference ID/Investigator# 5243 accredited by Crixeo Clinical Trials?

Site Reference ID/Investigator# 5243 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site Reference ID/Investigator# 5243?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.